Systematic review / meta-analysis / 2020
Resveratrol supplementation increased GPx levels but did not significantly alter SOD, MDA, or TAC in a meta-analysis of 16 trials.
A systematic review and meta-analysis of 16 clinical trials assessed the effect of resveratrol supplementation versus placebo on oxidative stress parameters. Resveratrol significantly increased serum GPx levels (WMD: 18.61; 95% CI: 8.70 to 28.52; P<0.001). However, it had no significant effect on SOD concentrations (WMD: 1.01; 95% CI: -0.72 to 2.74; P=0.25), MDA serum levels (WMD: -1.43; 95% CI: -3.46 to 0.61; P=0.17), or TAC (WMD: -0.09; 95% CI: -0.29 to 0.11; P=0.36). The authors observed that resveratrol supplementation may not have a clinically significant effect on oxidative stress.
- Study type
- Systematic review and meta-analysis of randomized clinical trials
- Who was studied
- Participants across 16 clinical trials
- What was measured
- GPx, SOD, MDA, and TAC serum levels
THE PAPER
The Effects of Resveratrol on Oxidative Stress Markers: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Omidian M, Abdolahi M, Daneshzad E, Sedighiyan M, Aghasi M, Abdollahi H, Omidian P, Dabiri S, Mahmoudi M. Endocr Metab Immune Disord Drug Targets, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.